BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9804354)

  • 21. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.
    Chavanas S; Gache Y; Tadini G; Pulkkinen L; Uitto J; Ortonne JP; Meneguzzi G
    J Invest Dermatol; 1997 Jul; 109(1):74-8. PubMed ID: 9204958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Academy of Dermatology 1997 Awards for Young Investigators in Dermatology. Mutational analysis of the bullous pemphigoid antigen 2/type XVII collagen gene in patients with generalized atrophic benign epidermolysis bullosa.
    Darling TN
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):773-4. PubMed ID: 9366826
    [No Abstract]   [Full Text] [Related]  

  • 25. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.
    Darling TN; Yee C; Bauer JW; Hintner H; Yancey KB
    J Clin Invest; 1999 May; 103(10):1371-7. PubMed ID: 10330419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.
    Nakano A; Lestringant GG; Paperna T; Bergman R; Gershoni R; Frossard P; Kanaan M; Meneguzzi G; Richard G; Pfendner E; Uitto J; Pulkkinen L; Sprecher E
    J Am Acad Dermatol; 2002 Apr; 46(4):510-6. PubMed ID: 11907499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bullous pemphigoid antigens (BPAGs): identification of RFLPs in human BPAG1 and BPAG2, and exclusion as candidate genes in a large kindred with dominant epidermolysis bullosa simplex.
    Ryynänen M; Knowlton RG; Kero M; Sawamura D; Li KH; Giudice GJ; Diaz LA; Uitto J
    Genomics; 1991 Dec; 11(4):1025-9. PubMed ID: 1686013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
    Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
    Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy.
    Bauer JW; Lanschuetzer C
    Clin Exp Dermatol; 2003 Jan; 28(1):53-60. PubMed ID: 12558632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemizygosity for a glycine substitution in collagen XVII: unfolding and degradation of the ectodomain.
    Tasanen K; Floeth M; Schumann H; Bruckner-Tuderman L
    J Invest Dermatol; 2000 Aug; 115(2):207-12. PubMed ID: 10951237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa.
    Bruckner-Tuderman L; Rüegger S; Odermatt B; Mitsuhashi Y; Schnyder UW
    Dermatologica; 1988; 176(2):57-64. PubMed ID: 3286309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of gene expression profiles in keratinocytes from patients with generalized atrophic benign epidermolysis bullosa.
    Huber A; Yee C; Darling TN; Yancey KB
    Exp Dermatol; 2002 Feb; 11(1):75-81. PubMed ID: 11952829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas.
    Swensson O; Christophers E
    Arch Dermatol; 1998 Feb; 134(2):199-203. PubMed ID: 9487212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180.
    Yamauchi T; Matsushita S; Hashimoto T; Hirako Y
    J Dermatol Sci; 2014 Oct; 76(1):25-33. PubMed ID: 25176590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa.
    Shimizu H; Sato M; Ban M; Kitajima Y; Ishizaki S; Harada T; Bruckner-Tuderman L; Fine JD; Burgeson R; Kon A; McGrath JA; Christiano AM; Uitto J; Nishikawa T
    Arch Dermatol; 1997 Sep; 133(9):1111-7. PubMed ID: 9301588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa.
    Mellerio JE; Denyer JE; Atherton DJ; Eady RA; McGrath JA
    Br J Dermatol; 1998 Apr; 138(4):661-6. PubMed ID: 9640376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.